New study aims to boost statin use with simple doctor nudges

NCT ID NCT05537064

Ongoing Disease control Sponsor: University of Pennsylvania Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests two methods to increase referrals to a centralized pharmacy service for managing statin therapy in patients with or at high risk for heart disease. One method sends reminders to doctors during office visits, and the other sends electronic messages outside of visits. The goal is to see if these nudges help more eligible patients get prescribed a statin, a common cholesterol-lowering medication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (nudge messages to doctors)
What this could lead to: If successful, this could show simple ways to help more patients get the right cholesterol medication, potentially reducing heart attacks and strokes.
What could go wrong: This is a pilot study testing methods to increase referrals, not a direct test of a new drug. Results may not apply to other settings, and the impact on actual health outcomes is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC VASCULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atherosclerosis hyperlipidemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERLIPIDEMIAS

Contacts and locations

Show contact details

Locations

Lancaster General Hospital

Lancaster, Pennsylvania, 17602, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.